Gaingels GeN 1E Lifesciences LLC — Form D

Gaingels GeN 1E Lifesciences LLC of BURLINGTON, VT, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-17. The offering totals $110K, of which $110K was reported sold. Industry: Other.

Offering

• Filed: 2023-01-17
• Form: D
• Accession: 0001956267-23-000005
• Industry: Other
• Exemptions: 06b
• Total offering: $110K
• Amount sold: $110K
• Minimum investment: $574
• Investors: 9
• Date of first sale: 2023-01-10
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-470809

Issuer

• Name: Gaingels GeN 1E Lifesciences LLC
• CIK: 0001960505
• Entity type: Limited Liability Company
• Jurisdiction: VERMONT
• Incorporated: 2022
• Address: C/O GAINGELS MANAGEMENT LLC, BURLINGTON, VT, 05401
• Phone: 2124047343

Officers, directors & promoters (1)

More

• CIK 1960505 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search